Intratect 50 g/l, solution for infusion (1g in 20ml) Malta - English - Medicines Authority

intratect 50 g/l, solution for infusion (1g in 20ml)

biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - human normal, immunoglobulin - solution for infusion - human normal immunoglobulin 50 mg/ml - immune sera and immunoglobulins

Intratect 100 g/l, solution for infusion (vial of 10 ml contains 1g) Malta - English - Medicines Authority

intratect 100 g/l, solution for infusion (vial of 10 ml contains 1g)

biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - albumin, human - solution for infusion - albumin, human 10 % (w/v) - immune sera and immunoglobulins

Intratect 100 g/l, solution for infusion (vial of 50 ml contains 5g) Malta - English - Medicines Authority

intratect 100 g/l, solution for infusion (vial of 50 ml contains 5g)

biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - human normal, immunoglobulin - solution for infusion - human normal immunoglobulin 100 mg/ml - immune sera and immunoglobulins

Intratect 100 g/l, solution for infusion (vial of 100 ml contains 10g) Malta - English - Medicines Authority

intratect 100 g/l, solution for infusion (vial of 100 ml contains 10g)

biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - human normal, immunoglobulin - solution for infusion - human normal immunoglobulin 100 mg/ml - immune sera and immunoglobulins

Intratect 100 g/l, solution for infusion (vial of 200 ml contains 20g) Malta - English - Medicines Authority

intratect 100 g/l, solution for infusion (vial of 200 ml contains 20g)

biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - human normal, immunoglobulin - solution for infusion - human normal immunoglobulin 100 mg/ml - immune sera and immunoglobulins

Zutectra European Union - English - EMA (European Medicines Agency)

zutectra

biotest pharma gmbh - human hepatitis b immunoglobulin - immunization, passive; hepatitis b; liver transplantation - immune sera and immunoglobulins, - prevention of hepatitis b virus (hbv) re-infection in hbsag and hbv-dna negative adult patients at least one week after liver transplantation for hepatitis b induced liver failure. hbv-dna negative status should be confirmed within the last 3 months prior to olt. patients should be hbsag negative before treatment start. the concomitant use of adequate virostatic agents should be considered as standard of hepatitis b re-infection prophylaxis.,

Hepatect CP 50 IU/ml; solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

hepatect cp 50 iu/ml; solution for infusion

biotest pharma gmbh - human plasma protein; hbs antibodies - solution for infusion - 50 international unit(s)/millilitre - specific immunoglobulins; hepatitis b immunoglobulin

Intratect 100 g/L, solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

intratect 100 g/l, solution for infusion

biotest pharma gmbh - human plasma protein - solution for infusion - 100 gram(s)/litre - immunoglobulins, normal human; immunoglobulins, normal human, for intravascular adm.

Megalotect 100 U/mL solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

megalotect 100 u/ml solution for infusion

biotest pharma gmbh - human cytomegalovirus immunoglobulin - solution for infusion - cytomegalovirus immunoglobulin

Intratect 50 g/L, solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

intratect 50 g/l, solution for infusion

biotest pharma gmbh - human plasma protein >96% immunoglobulins - solution for infusion - 50 gram(s)/litre - immunoglobulins, normal human; immunoglobulins, normal human, for intravascular adm.